NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/16/2026
Back to search
Official data from USPTO
G GENEFAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
06/16/2026
Classification
Registered
Trademark type
Combined
Nice classes
1, 42
Filing date
07/22/2024
Registration date
06/16/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2026
Last transaction
06/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
2025-03-00
First use in commerce
2025-03-00
Drawing code
5
Owner type
16
Owner location
Alameda, CA, US
Examiner
MORENO, PAUL A
Law office
L30
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylize letter "G" followed by the stylized word "GENEFAB".
Holders and representatives
Holders
GeneFab, LLC
Representatives
Grace Han Stanton Perkins Coie LLP
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Cells for scientific and research use; cells for scientificlaboratorymedical research; genetic material for scientific and research use; genetic material for scientificlaboratorymedical research
Class 42
Research and development of pharmaceutical preparations and substances; scientific research and development; medical research and development; research and development in the field of gene therapy; Testing of pharmaceuticalsproviding designtesting and manufacturing services for cell and gene therapies
Publications
History of USPTO decisions and trademark events.
28 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/16/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/27/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/27/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/30/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/30/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/03/2025
IUAF
USE AMENDMENT FILED
12/02/2025
EISU
TEAS STATEMENT OF USE RECEIVED
12/02/2025
EX1G
SOU EXTENSION 1 GRANTED
12/02/2025
EXT1
SOU EXTENSION 1 FILED
12/02/2025
EEXT
SOU TEAS EXTENSION RECEIVED
12/02/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/08/2025
PUBO
PUBLISHED FOR OPPOSITION
04/08/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/02/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
03/13/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/05/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/05/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/05/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/05/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/13/2025
GNRT
NON-FINAL ACTION E-MAILED
02/13/2025
CNRT
NON-FINAL ACTION WRITTEN
02/13/2025
DOCK
ASSIGNED TO EXAMINER
02/10/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/09/2025
NWAP
NEW APPLICATION ENTERED
07/22/2024
Continuous trademark protection
Get notified about every new filing that threatens G GENEFAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.